MedPath

Evaluation of postoperative quality of life after Billroth-I distal gastrectomy and pylorus-preserving gastrectomy for Stage I gastric cancer

Not Applicable
Conditions
gastric cancer
Registration Number
JPRN-UMIN000021131
Lead Sponsor
Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open public recruiting
Sex
All
Target Recruitment
128
Inclusion Criteria

1) pathologically-confirmed gastric cancer (papillary adenocarcinoma, tubular adenocarcinoma, poorly differentiated adenocarcinoma, signet ring cell carcinoma and mucinous adenocarcinoma)
2) cStage IA or IB, but not T2 tumor at the greater curvature of the stomach
3) No indication of endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) in a cN0 or cN1case
4) Patients who underwent EMR or ESD and need additional surgery
5) Aged 20 to 80 year
6) PS (ECOG) 0 or 1
7) No history of gastrointestinal surgery
8) No history of chemotherapy or radiotherapy
9) Capability of filling out a survey independently
10) Provided written informed consent

Exclusion Criteria

1) Synchronous or metachronous malignancies other than carcinoma in situ
2) Simultaneous surgery other than cholecystectomy
3) Any other medical condition that makes the patient unsuitable for inclusion in the study according to the opinion of the investigator

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To demonstrate the superiority of pylorus-preserving gastrectomy over distal gastrectomy in postoperative dumping syndrome incidence.
Secondary Outcome Measures
NameTimeMethod
quality of life (PGSAS37?EORTC), operative time, intraoperative blood loss, morbidity, mortality, short-term mortality
© Copyright 2025. All Rights Reserved by MedPath